Deerfield Management Company, L.P. (Series C) Nkarta, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.76 Billion
- Q2 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Nkarta, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,799,143 shares of NKTX stock, worth $17.2 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
3,799,143
Previous 5,194,087
26.86%
Holding current value
$17.2 Million
Previous $56.1 Million
60.01%
% of portfolio
0.47%
Previous 1.16%
Shares
7 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
66.2MCall Options Held
142KPut Options Held
43.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$48.8 Million0.96% of portfolio
-
Boxer Capital, LLC San Diego, CA5.61MShares$25.3 Million1.84% of portfolio
-
Commodore Capital LP New York, NY4.15MShares$18.8 Million2.2% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$18.3 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$17 Million11.45% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $220M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...